Promoting and facilitating strategies to improve cardiovascular health worldwide

Tratamiento con ACOD en pacientes con FA post-ICP

ISCP On-Demand Webinar











ISCP Webinar: Cardiovascular Risk Management of Diabetes and SGLT2 Inhibitors

 

newsfeed

Finerenone effective in reducing cardiac, ESKD risk in patients with diabetes

Posted on October 24, 2020

Data presented at ASN Kidney Week showed the mineralocorticoid receptor inhibitor antagonist finerenone was effective in reducing cardiac risk and slowing the... more

Larger dietary patterns, more so than individual factors, influence cardiometabolic health

Posted on October 24, 2020

Body weight, macronutrient distribution and sodium intake are all factors that need to be considered in the management of cardiometabolic risk factors... more

Physical activity volume, motivation key to maintaining weight loss post-obesity

Posted on October 24, 2020

Providers should focus on the volume of physical activity performed by individuals with obesity and motivate them to get the most success... more

Dapagliflozin reduces risks of kidney failure, cardiovascular or renal death

Posted on October 24, 2020

Dapagliflozin reduced the worsening of kidney function and the risk of cardiovascular or renal death in patients with chronic kidney disease irrespective... more

ISCP book series

Current Cardiovascular Therapy
Kaski, Juan Carlos.

Series Editor: Juan Carlos Kaski Cardiovascular pharmacotherapy is a fast-moving and complex discipline within cardiology in general. New studies, trials and indications are appearing on a regular basis. This series created with the support of the International Society of Cardiovascular Pharmacotherapy (ISCP) is designed to establish the baseline level of knowledge that a cardiovascular professional needs to know on a day-to-day basis. The information within is designed to allow readers to learn quickly and with certainty the mode of action,...

  • Antiplatelet and Anticoagulation Therapy

    A. Ferro, D.A. Garcia (Eds.)

  • Pharmacological Treatment of Acute Coronary Syndromes

    Avanzas, Pablo; Clemmensen, Peter(Eds.)

  • Atrial Fibrillation Therapy

    Gheorghe-Andrei Dan, Antoni Bayes de Luna, John Camm(Eds.)

board of directors

Providing a leadership and advocacy role amongst members of their national societies.

 

  •  Hector Ventura

    President

    Affiliations/Memberships Section Head, Cardiomyopathy and Heart Transplant Director, Cardiovascular Disease Training Program (more…) more

  •  Jack Tan

    President-elect

    Dr Jack Tan graduated from the Faculty of Medicine, National University of Singapore in 1997. In 2007, he spent one year at UC Davis (more…) more

  •  Pablo Avanzas

    Secretary

    Affiliations/Memberships Consultant in Invasive Cardiology, Hospital Universitario Central de Asturias, Oviedo, Spain Fellow of the European Society (more…) more

  •  Thomas Kahan

    Treasurer

    Affiliations/Memberships Professor of Medicine Department of Clinical Sciences, Danderyd Hospital Division of Cardiovascular Medicine (more…) more